Maze Therapeutics Inc. (MAZE)
NASDAQ · Healthcare
Maze Therapeutics Inc. EPS 2024–2024
Maze Therapeutics Inc. annual/quarterly eps history and growth rate from 2024 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Maze Therapeutics Inc. eps for the quarter ending March 31, 2026 was $0.45.
- Maze Therapeutics Inc. annual eps for 2024 was $1.25.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Maze Therapeutics Inc. EPS — FAQ
Maze Therapeutics Inc. (MAZE) eps over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
What is Maze Therapeutics Inc.'s eps?
Maze Therapeutics Inc. (MAZE) reported eps of $1.25 for fiscal 2024.
Where can I see MAZE's eps history?
The chart and table above show Maze Therapeutics Inc.'s eps by year and by quarter, including the growth rate.